These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 22956286

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. EGFR and HER2 exert distinct roles on colon cancer cell functional properties and expression of matrix macromolecules.
    Ellina MI, Bouris P, Aletras AJ, Theocharis AD, Kletsas D, Karamanos NK.
    Biochim Biophys Acta; 2014 Aug; 1840(8):2651-61. PubMed ID: 24792576
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of EGF/EGFR activation with naphtho[1,2-b]furan-4,5-dione blocks migration and invasion of MDA-MB-231 cells.
    Hsieh CY, Tsai PC, Tseng CH, Chen YL, Chang LS, Lin SR.
    Toxicol In Vitro; 2013 Feb; 27(1):1-10. PubMed ID: 23064031
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. EGF receptor transactivation by urokinase receptor stimulus through a mechanism involving Src and matrix metalloproteinases.
    Guerrero J, Santibañez JF, González A, Martínez J.
    Exp Cell Res; 2004 Jan 01; 292(1):201-8. PubMed ID: 14720519
    [Abstract] [Full Text] [Related]

  • 7. Docosahexaenoic Acid Downregulates EGF-Induced Urokinase Plasminogen Activator and Matrix Metalloproteinase 9 Expression by Inactivating EGFR/ErbB2 Signaling in SK-BR3 Breast Cancer Cells.
    Li CC, Yao HT, Cheng FJ, Hsieh YH, Lu CY, Wu CC, Liu KL, Chang JW.
    Nutr Cancer; 2015 Jan 01; 67(5):771-82. PubMed ID: 25970488
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Adhesion, actin cytoskeleton organisation and the spreading of colon adenocarcinoma cells induced by EGF are mediated by alpha2beta1 integrin low clustering through focal adhesion kinase.
    Pichard V, Honoré S, Kovacic H, Li C, Prevôt C, Briand C, Rognoni JB.
    Histochem Cell Biol; 2001 Oct 01; 116(4):337-48. PubMed ID: 11702192
    [Abstract] [Full Text] [Related]

  • 10. Combined inhibition of EMMPRIN and epidermal growth factor receptor prevents the growth and migration of head and neck squamous cell carcinoma cells.
    Suzuki S, Ishikawa K.
    Int J Oncol; 2014 Mar 01; 44(3):912-7. PubMed ID: 24379084
    [Abstract] [Full Text] [Related]

  • 11. Epidermal growth factor stimulates urokinase-type plasminogen activator expression in human gingival fibroblasts. Possible modulation by genistein and curcumin.
    Smith PC, Santibañez JF, Morales JP, Martinez J.
    J Periodontal Res; 2004 Dec 01; 39(6):380-7. PubMed ID: 15491342
    [Abstract] [Full Text] [Related]

  • 12. Curcumin attenuates hyperglycemia-driven EGF-induced invasive and migratory abilities of pancreatic cancer via suppression of the ERK and AKT pathways.
    Li W, Wang Z, Xiao X, Han L, Wu Z, Ma Q, Cao L.
    Oncol Rep; 2019 Jan 01; 41(1):650-658. PubMed ID: 30542713
    [Abstract] [Full Text] [Related]

  • 13. Epidermal growth factor receptor-mediated regulation of urokinase plasminogen activator expression and glioblastoma invasion via C-SRC/MAPK/AP-1 signaling pathways.
    Amos S, Redpath GT, Dipierro CG, Carpenter JE, Hussaini IM.
    J Neuropathol Exp Neurol; 2010 Jun 01; 69(6):582-92. PubMed ID: 20467333
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Differential modulation of proliferation, matrix metalloproteinase expression and invasion of human head and neck squamous carcinoma cells by c-erbB ligands.
    O-charoenrat P, Rhys-Evans P, Court WJ, Box GM, Eccles SA.
    Clin Exp Metastasis; 1999 Jun 01; 17(7):631-9. PubMed ID: 10845563
    [Abstract] [Full Text] [Related]

  • 16. Matrix metalloproteinase-7-catalyzed release of HB-EGF mediates deoxycholyltaurine-induced proliferation of a human colon cancer cell line.
    Cheng K, Xie G, Raufman JP.
    Biochem Pharmacol; 2007 Apr 01; 73(7):1001-12. PubMed ID: 17222808
    [Abstract] [Full Text] [Related]

  • 17. Urokinase receptor primes cells to proliferate in response to epidermal growth factor.
    Jo M, Thomas KS, Takimoto S, Gaultier A, Hsieh EH, Lester RD, Gonias SL.
    Oncogene; 2007 Apr 19; 26(18):2585-94. PubMed ID: 17043637
    [Abstract] [Full Text] [Related]

  • 18. Epidermal growth factor receptor-mediated membrane type 1 matrix metalloproteinase endocytosis regulates the transition between invasive versus expansive growth of ovarian carcinoma cells in three-dimensional collagen.
    Moss NM, Liu Y, Johnson JJ, Debiase P, Jones J, Hudson LG, Munshi HG, Stack MS.
    Mol Cancer Res; 2009 Jun 19; 7(6):809-20. PubMed ID: 19509114
    [Abstract] [Full Text] [Related]

  • 19. Epidermal growth factor receptor-mediated regulation of matrix metalloproteinase-2 and matrix metalloproteinase-9 in MCF-7 breast cancer cells.
    Majumder A, Ray S, Banerji A.
    Mol Cell Biochem; 2019 Feb 19; 452(1-2):111-121. PubMed ID: 30074136
    [Abstract] [Full Text] [Related]

  • 20. Epidermal growth factor receptor (EGFR)-related protein inhibits multiple members of the EGFR family in colon and breast cancer cells.
    Xu H, Yu Y, Marciniak D, Rishi AK, Sarkar FH, Kucuk O, Majumdar AP.
    Mol Cancer Ther; 2005 Mar 19; 4(3):435-42. PubMed ID: 15767552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.